Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323825217> ?p ?o ?g. }
- W4323825217 endingPage "673" @default.
- W4323825217 startingPage "657" @default.
- W4323825217 abstract "Abstract It is generally believed that histone deacetylase (HDAC) inhibitors, which represent a new class of anticancer agents, exert their antitumor activity by directly causing cell-cycle arrest and apoptosis of tumor cells. However, in this study, we demonstrated that class I HDAC inhibitors, such as Entinostat and Panobinostat, effectively suppressed tumor growth in immunocompetent but not immunodeficient mice. Further studies with Hdac1, 2, or 3 knockout tumor cells indicated that tumor-specific inactivation of HDAC3 suppressed tumor growth by activating antitumor immunity. Specifically, we found that HDAC3 could directly bind to promotor regions and inhibit the expression of CXCL9, 10, and 11 chemokines. Hdac3-deficient tumor cells expressed high levels of these chemokines, which suppressed tumor growth in immunocompetent mice by recruiting CXCR3+ T cells into the tumor microenvironment (TME). Furthermore, the inverse correlation between HDAC3 and CXCL10 expression in hepatocellular carcinoma tumor tissues also suggested HDAC3 might be involved in antitumor immune regulation and patient survival. Thus, our studies have illustrated that HDAC3 inhibition suppresses tumor growth by enhancing immune cell infiltration into the TME. This antitumor mechanism may be helpful in guiding HDAC3 inhibitor–based treatment." @default.
- W4323825217 created "2023-03-11" @default.
- W4323825217 creator A5009516775 @default.
- W4323825217 creator A5013437001 @default.
- W4323825217 creator A5014056348 @default.
- W4323825217 creator A5017234075 @default.
- W4323825217 creator A5021174216 @default.
- W4323825217 creator A5084087830 @default.
- W4323825217 creator A5090045997 @default.
- W4323825217 creator A5091700292 @default.
- W4323825217 date "2023-02-27" @default.
- W4323825217 modified "2023-10-01" @default.
- W4323825217 title "HDAC3 inhibition promotes anti-tumor immunity by enhancing CXCL10 mediated chemotaxis and recruiting of immune cells" @default.
- W4323825217 cites W1487070667 @default.
- W4323825217 cites W1648913866 @default.
- W4323825217 cites W1811130292 @default.
- W4323825217 cites W1964613018 @default.
- W4323825217 cites W1978527149 @default.
- W4323825217 cites W1980757449 @default.
- W4323825217 cites W1993474911 @default.
- W4323825217 cites W1997671473 @default.
- W4323825217 cites W2014237818 @default.
- W4323825217 cites W2014497537 @default.
- W4323825217 cites W2016982251 @default.
- W4323825217 cites W2019552331 @default.
- W4323825217 cites W2029148944 @default.
- W4323825217 cites W2043514699 @default.
- W4323825217 cites W2059002036 @default.
- W4323825217 cites W2060833045 @default.
- W4323825217 cites W2074905595 @default.
- W4323825217 cites W2107733280 @default.
- W4323825217 cites W2149370967 @default.
- W4323825217 cites W2159861093 @default.
- W4323825217 cites W2172076789 @default.
- W4323825217 cites W2271364972 @default.
- W4323825217 cites W2475853404 @default.
- W4323825217 cites W2479346408 @default.
- W4323825217 cites W2531449940 @default.
- W4323825217 cites W2607436472 @default.
- W4323825217 cites W2753321883 @default.
- W4323825217 cites W2770893462 @default.
- W4323825217 cites W2791709427 @default.
- W4323825217 cites W2792323180 @default.
- W4323825217 cites W2794041272 @default.
- W4323825217 cites W2796023996 @default.
- W4323825217 cites W2898692674 @default.
- W4323825217 cites W2900640488 @default.
- W4323825217 cites W2909413229 @default.
- W4323825217 cites W2911977097 @default.
- W4323825217 cites W2945224722 @default.
- W4323825217 cites W2946750306 @default.
- W4323825217 cites W2998650473 @default.
- W4323825217 cites W3000215297 @default.
- W4323825217 cites W3007726756 @default.
- W4323825217 cites W3038099138 @default.
- W4323825217 cites W3045859819 @default.
- W4323825217 cites W3047311641 @default.
- W4323825217 cites W3087483200 @default.
- W4323825217 cites W3134028174 @default.
- W4323825217 cites W3172226874 @default.
- W4323825217 cites W3199341362 @default.
- W4323825217 cites W4205491929 @default.
- W4323825217 cites W4297464616 @default.
- W4323825217 doi "https://doi.org/10.1158/2326-6066.cir-22-0317" @default.
- W4323825217 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36898011" @default.
- W4323825217 hasPublicationYear "2023" @default.
- W4323825217 type Work @default.
- W4323825217 citedByCount "2" @default.
- W4323825217 countsByYear W43238252172023 @default.
- W4323825217 crossrefType "journal-article" @default.
- W4323825217 hasAuthorship W4323825217A5009516775 @default.
- W4323825217 hasAuthorship W4323825217A5013437001 @default.
- W4323825217 hasAuthorship W4323825217A5014056348 @default.
- W4323825217 hasAuthorship W4323825217A5017234075 @default.
- W4323825217 hasAuthorship W4323825217A5021174216 @default.
- W4323825217 hasAuthorship W4323825217A5084087830 @default.
- W4323825217 hasAuthorship W4323825217A5090045997 @default.
- W4323825217 hasAuthorship W4323825217A5091700292 @default.
- W4323825217 hasBestOaLocation W43238252171 @default.
- W4323825217 hasConcept C104317684 @default.
- W4323825217 hasConcept C13373296 @default.
- W4323825217 hasConcept C13721689 @default.
- W4323825217 hasConcept C154317977 @default.
- W4323825217 hasConcept C17502307 @default.
- W4323825217 hasConcept C185592680 @default.
- W4323825217 hasConcept C202751555 @default.
- W4323825217 hasConcept C203014093 @default.
- W4323825217 hasConcept C2776107976 @default.
- W4323825217 hasConcept C2778305200 @default.
- W4323825217 hasConcept C502942594 @default.
- W4323825217 hasConcept C55493867 @default.
- W4323825217 hasConcept C5858377 @default.
- W4323825217 hasConcept C64927066 @default.
- W4323825217 hasConcept C85240754 @default.
- W4323825217 hasConcept C86803240 @default.
- W4323825217 hasConcept C8891405 @default.
- W4323825217 hasConceptScore W4323825217C104317684 @default.
- W4323825217 hasConceptScore W4323825217C13373296 @default.